PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 146 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2019. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $20,000 | -9.1% | 1,890 | +11.6% | 0.00% | 0.0% |
| Q2 2019 | $22,000 | -66.7% | 1,694 | -0.6% | 0.00% | -86.7% |
| Q1 2019 | $66,000 | +106.2% | 1,705 | +8.6% | 0.02% | +87.5% |
| Q4 2018 | $32,000 | -51.5% | 1,570 | +8.3% | 0.01% | -38.5% |
| Q3 2018 | $66,000 | -16.5% | 1,450 | +8.6% | 0.01% | -18.8% |
| Q2 2018 | $79,000 | -86.9% | 1,335 | -47.5% | 0.02% | -68.0% |
| Q1 2015 | $601,000 | +67.9% | 2,544 | +34.7% | 0.05% | +66.7% |
| Q4 2014 | $358,000 | -12.5% | 1,888 | +10.0% | 0.03% | -9.1% |
| Q3 2014 | $409,000 | +101.5% | 1,717 | -44.3% | 0.03% | +106.2% |
| Q2 2014 | $203,000 | -73.8% | 3,082 | -58.5% | 0.02% | -71.4% |
| Q1 2014 | $774,000 | +46.6% | 7,427 | +45.6% | 0.06% | +36.6% |
| Q4 2013 | $528,000 | – | 5,100 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |